|Date & Time||15 March 2022 at 09:00-11:30 CET|
The management of pharmaceutical pricing and reimbursement (P&R) decisions in European countries and e.g., the USA differs a lot. In addition, the market access route between different Health Tech products is different and the private and public sector practices vary per country. The awareness of these issues is important as companies may face many challenges. Therefore, you are welcome to join this webinar hosted by Turku Science Park Ltd, and dedicated to the pricing and reimbursement systems of pharmaceuticals. Another webinar about pricing and reimbursement strategies for MedTech products will be arranged on 22 March 2022.
The webinar outlines shortly the pricing and reimbursement systems of Finland, Germany, UK, France, and the USA. Pricing and Reimbursement are linked to Health Technology Assessment (HTA) systems, are affected by Treatment Guidelines, and should be considered already in the clinical trial planning phase. The aim of this webinar is to explore the principles and practices used to assess whether a company’s product is eligible for the country’s reimbursement system. The webinar is intended for drug development and pharmaceutical companies who need more information on pricing and who want to expand their understanding of reimbursement systems in various important global markets.
10:00 -10:05 Introduction and background of the webinar, Turku Science Park Ltd
10:05 -10:30 Basics of pricing and reimbursement from the global perspective and market access in Finland, Juha Laine, Roche & University of Turku
10:30 -11:20 Basics of market access in Germany, UK and France, Susanne Sange, Bayer
11:20 -11:25 Short break
11:25 -11:40 Basics of market access in USA, Susanne Sange, Bayer
11:40~12:30 Questions & Answers
The webinar is partly funded by the Regional Council of Southwest Finland’s AKKE project that is supporting the sustainability and vitality of regions.